Peters GHJ - Search Results

1

Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system.

Zhou Y, Gammeltoft KA, Ryberg LA, Pham LV, Tjørnelund HD, Binderup A, Duarte Hernandez CR, Fernandez-Antunez C, Offersgaard A, Fahnøe U, Peters GHJ, Ramirez S, Bukh J, Gottwein JM. Zhou Y, et al. Among authors: peters ghj. Sci Adv. 2022 Dec 21;8(51):eadd7197. doi: 10.1126/sciadv.add7197. Epub 2022 Dec 21. Sci Adv. 2022. PMID: 36542720 Free PMC article.

2

Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir.

Gammeltoft KA, Zhou Y, Ryberg LA, Pham LV, Binderup A, Hernandez CRD, Offersgaard A, Fahnøe U, Peters GHJ, Ramirez S, Bukh J, Gottwein JM. Gammeltoft KA, et al. Among authors: peters ghj. Viruses. 2023 Sep 21;15(9):1970. doi: 10.3390/v15091970. Viruses. 2023. PMID: 37766376 Free PMC article. Review.

3

Candida antarctica lipase B performance in organic solvent at varying water activities studied by molecular dynamics simulations.

Tjørnelund HD, Vind J, Brask J, Woodley JM, Peters GHJ. Tjørnelund HD, et al. Among authors: peters ghj. Comput Struct Biotechnol J. 2023 Oct 31;21:5451-5462. doi: 10.1016/j.csbj.2023.10.049. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 38022691 Free PMC article.

4

Substrates and Cyclic Peptide Inhibitors of the Oligonucleotide-Activated Sirtuin 7.

Bolding JE, Nielsen AL, Jensen I, Hansen TN, Ryberg LA, Jameson ST, Harris P, Peters GHJ, Denu JM, Rogers JM, Olsen CA. Bolding JE, et al. Among authors: peters ghj. Angew Chem Int Ed Engl. 2023 Dec 4;62(49):e202314597. doi: 10.1002/anie.202314597. Epub 2023 Nov 7. Angew Chem Int Ed Engl. 2023. PMID: 37873919

5

Combining Molecular Dynamics Simulations and Biophysical Characterization to Investigate Protein-Specific Excipient Effects on Reteplase during Freeze Drying.

Ko SK, Björkengren G, Berner C, Winter G, Harris P, Peters GHJ. Ko SK, et al. Among authors: peters ghj. Pharmaceutics. 2023 Jun 30;15(7):1854. doi: 10.3390/pharmaceutics15071854. Pharmaceutics. 2023. PMID: 37514040 Free PMC article.

6

Chemometrics in Protein Formulation: Stability Governed by Repulsion and Protein Unfolding.

Kulakova A, Augustijn D, El Bialy I, Gentiluomo L, Greco ML, Hervø-Hansen S, Indrakumar S, Mahapatra S, Martinez Morales M, Pohl C, Polimeni M, Roche A, Svilenov HL, Tosstorff A, Zalar M, Curtis R, Derrick JP, Frieß W, Golovanov AP, Lund M, Nørgaard A, Khan TA, Peters GHJ, Pluen A, Roessner D, Streicher WW, van der Walle CF, Warwicker J, Uddin S, Winter G, Bukrinski JT, Rinnan Å, Harris P. Kulakova A, et al. Among authors: peters ghj. Mol Pharm. 2023 Jun 5;20(6):2951-2965. doi: 10.1021/acs.molpharmaceut.3c00013. Epub 2023 May 5. Mol Pharm. 2023. PMID: 37146162

7

Structural characterization of human tryptophan hydroxylase 2 reveals that L-Phe is superior to L-Trp as the regulatory domain ligand.

Vedel IM, Prestel A, Zhang Z, Skawinska NT, Stark H, Harris P, Kragelund BB, Peters GHJ. Vedel IM, et al. Among authors: peters ghj. Structure. 2023 Jun 1;31(6):689-699.e6. doi: 10.1016/j.str.2023.04.004. Epub 2023 Apr 28. Structure. 2023. PMID: 37119821

8

Templated Enzymatic Synthesis of δ-Cyclodextrin.

Erichsen A, Peters GHJ, Beeren SR. Erichsen A, et al. Among authors: peters ghj. J Am Chem Soc. 2023 Mar 1;145(8):4882-4891. doi: 10.1021/jacs.3c00341. Epub 2023 Feb 20. J Am Chem Soc. 2023. PMID: 36802551

9

Molecular insights into alginate β-lactoglobulin A multivalencies-The foundation for their amorphous aggregates and coacervation.

Madsen M, Prestel A, Madland E, Westh P, Tøndervik A, Sletta H, Peters GHJ, Aachmann FL, Kragelund BB, Svensson B. Madsen M, et al. Among authors: peters ghj. Protein Sci. 2023 Feb;32(2):e4556. doi: 10.1002/pro.4556. Protein Sci. 2023. PMID: 36571497 Free PMC article.

10

Dynamics of Human Serum Transferrin in Varying Physicochemical Conditions Explored by Using Molecular Dynamics Simulations.

Indrakumar S, Kulakova A, Harris P, Peters GHJ. Indrakumar S, et al. Among authors: peters ghj. Mol Pharm. 2022 Aug 1;19(8):2795-2806. doi: 10.1021/acs.molpharmaceut.2c00158. Epub 2022 Jul 1. Mol Pharm. 2022. PMID: 35776490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page